Skip to Content

Join the 'Avodart' group to help and get support from people like you.

Avodart News

Some Prostate Drugs May Do Harm

Posted 29 Jun 2017 by Drugs.com

THURSDAY, June 29, 2017 – Popular hormone-based drugs for treating an enlarged prostate could increase men's risk of type 2 diabetes, heart disease or stroke, a new study suggests. A group of German men taking the drug Avodart (dutasteride) for three years wound up with higher blood sugar and cholesterol levels than men taking another class of prostate medication that does not affect male ...

Drugs for Prostate Trouble, Balding Not Linked to Suicide Risk

Posted 20 Mar 2017 by Drugs.com

MONDAY, March 20, 2017 – Drugs used to treat enlarged prostate and male pattern baldness may raise an older man's risk of depression and self-harm, but not their risk of suicide, a new study finds. The study focused on a class of medications called 5a- reductase inhibitors (5ARIs), which include widely used drugs for male pattern baldness, such as Propecia, and Proscar, used to fight an enlarged ...

Drug May Slow Early Prostate Cancer: Study

Posted 24 Jan 2012 by Drugs.com

TUESDAY, Jan. 24 – New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men. Prostate cancer can grow and spread slowly, which is why some men are urged to engage in so-called watchful waiting when the cancer is first diagnosed. Avodart (dutasteride) ...

FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate

Posted 7 Oct 2011 by Drugs.com

THURSDAY, Oct. 6 – The U.S. Food and Drug Administration announced late Thursday that it had approved using the erectile dysfunction drug Cialis as a treatment for enlarged prostate. According to the U.S. National Institutes of Health, enlarged prostate – clinically known as benign prostatic hyperplasia (BPH) – is a "common part of aging" for men. In fact, the NIH estimates that "more than ...

Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer

Posted 9 Jun 2011 by Drugs.com

THURSDAY, June 9 – The U.S. Food and Drug Administration is calling for new warning labels on a class of drugs used primarily to treat enlarged prostates, because the medications may raise the risk of developing an aggressive form of prostate cancer. In a statement released Thursday, the agency said the drugs involved include popular medications sold under the brand names Proscar and Propecia ...

FDA Medwatch Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer

Posted 9 Jun 2011 by Drugs.com

Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn ISSUE: FDA notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include new safety information about the increased risk of being ...

Sexual Side Effects From Propecia, Avodart May Be Irreversible

Posted 10 Mar 2011 by Drugs.com

THURSDAY, March 10 – Drugs frequently prescribed to treat hair loss or an enlarged prostate may contribute to irreversible sexual dysfunction in men, new research finds. Use of dutasteride (Avodart) and finasteride (Proscar and Propecia) were linked to erectile dysfunction, depression and loss of libido in a review of existing studies. In a small percentage of cases, symptoms persisted even ...

FDA Panel to Vote on Drugs to Prevent Prostate Cancer

Posted 1 Dec 2010 by Drugs.com

WEDNESDAY, Dec. 1 – A U.S. Food and Drug Administration advisory panel is expected to decide Wednesday whether to approve two drugs for the prevention of prostate cancer, the third highest cancer killer of men. Avodart and Proscar, manufactured by GlaxoSmithKline and Merck, respectively, are already approved to treat enlarged prostates. The drug makers say their research shows the drugs also ...

Study Revives Debate on Prostate Drug

Posted 2 Apr 2010 by Drugs.com

WEDNESDAY, March 31 – A new study to determine whether a drug prescribed to fight the problems of an enlarged prostate gland can also reduce the risk of prostate cancer promises to prolong a debate that started with an earlier study of a similar drug. The renewed debate plays out in the April 1 issue of the New England Journal of Medicine, which carries not only a report saying that the drug ...

Prostate Meds Not Tied to Increased Hip Fracture Risk

Posted 7 Oct 2008 by Drugs.com

TUESDAY, Oct. 7 – A new study found no link between the use of a drug to treat an enlarged prostate and an increase in hip fractures in men. The study, published in the Oct. 8 issue of the Journal of the American Medical Association, does not completely clear the class of medications known as 5-a reductase inhibitors, because it did not find out how the drugs affect long-term bone health. The ...

Ask a Question

Further Information

Related Condition Support Groups

Benign Prostatic Hyperplasia (BPH)

Avodart Patient Information at Drugs.com